Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Outcome of Noac Exposure during Pregnancy (...and the problem of event reporting...)

Jan Beyer-Westendorf, MD, Sandra Marten, MD, Franziska Michalski, MD

Blood (2015) 126 (23): 1125.

https://doi.org/10.1182/blood.V126.23.1125.1125

Published: 2015

Journal Articles

Drug Persistence with Rivaroxaban Therapy in Atrial Fibrillation Patients Results from the Dresden NOAC registry

Jan Beyer-Westendorf, MD, Kati Förster, Franziska Ebertz, Vera Gelbricht, Franziska Michalski, Luise Tittl, Norbert Weiss, Prof.

Blood (2014) 124 (21): 4264.

https://doi.org/10.1182/blood.V124.21.4264.4264

Published: 2014

Journal Articles

Centrally Adjudicated Cause of Death during Noac Treatment – Results of the Prospective Dresden Noac Registry (NCT01588119)

Franziska Michalski, Sebastian Werth, MD, Christina Köhler, MD, Luise Tittl, Katharina Daschkow, Jan Beyer-Westendorf, MD

Blood (2014) 124 (21): 2876.

https://doi.org/10.1182/blood.V124.21.2876.2876

Published: 2014

Journal Articles

Characteristics of Atrial Fibrillation Patients Not Switched from Vka to Noac and Persistence on Vka – a Subgroup Analysis of the Prospective Dresden Noac Registry (NCT01588119)

Jan Beyer-Westendorf, MD, Franziska Michalski, Sebastian Werth, MD, Luise Tittl, Christina Köhler, MD, Norbert Weiss, Prof.

Blood (2014) 124 (21): 1538.

https://doi.org/10.1182/blood.V124.21.1538.1538

Published: 2014

Journal Articles

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Franziska Ebertz, Sebastian Werth, MD, Christina Köhler, MD, Franziska Michalski, Ulrike Hänsel, Luise Tittl, Katharina Daschkow, Thomas Schreier, Jan Beyer-Westendorf, MD

Blood (2014) 124 (21): 1541.

https://doi.org/10.1182/blood.V124.21.1541.1541

Published: 2014

Journal Articles

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Jan Beyer-Westendorf, Kati Förster, Sven Pannach, Franziska Ebertz, Vera Gelbricht, Christoph Thieme, Franziska Michalski, Christina Köhler, Sebastian Werth, Kurtulus Sahin, Luise Tittl, Ulrike Hänsel, Norbert Weiss

Blood (2014) 124 (6): 955–962.

https://doi.org/10.1182/blood-2014-03-563577

Published: 2014

Includes: Supplemental data

NARROW

Outcome of Noac Exposure during Pregnancy (...and the problem of event reporting...)

Drug Persistence with Rivaroxaban Therapy in Atrial Fibrillation Patients Results from the Dresden NOAC registry

Centrally Adjudicated Cause of Death during Noac Treatment – Results of the Prospective Dresden Noac Registry (NCT01588119)

Characteristics of Atrial Fibrillation Patients Not Switched from Vka to Noac and Persistence on Vka – a Subgroup Analysis of the Prospective Dresden Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Email alerts

ASH Publications

American Society of Hematology

Outcome of Noac Exposure during Pregnancy (...and the problem of event reporting...)

Drug Persistence with Rivaroxaban Therapy in Atrial Fibrillation Patients Results from the Dresden NOAC registry

Centrally Adjudicated Cause of Death during Noac Treatment – Results of the Prospective Dresden Noac Registry (NCT01588119)

Characteristics of Atrial Fibrillation Patients Not Switched from Vka to Noac and Persistence on Vka – a Subgroup Analysis of the Prospective Dresden Noac Registry (NCT01588119)

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only